Skip to main content

Table 1 Summary of method validation data

From: Targeted CYP2E1 quantification and its correlation to currently acceptable clinical biochemical indices

Parameters

YPEIEEK (P1)

GTVVVPTLDSVLYDNQEFPDPEK (P2)

IS-P1

IS-P2

Linear range

5–100,000 fg/µl

100–12,500 fg/µl

NA

NA

Linearity

r2 = 0.991 ± 0.007

r2 = 0.998 ± 0.001

NA

NA

LLOQ

5 fg/µl

100 fg/µl

NA

NA

Specificity

CV = 4.0 ± 0.04 %

CV = 15.9 ± 0.42 %

CV = 2.42 ± 0.05 %

CV = 14.2 ± 0.57 %

Quality control:

L

M

H

L

M

H

NA

NA

Intra-day

 Accuracy, %

99.2

99.8

98.2

41.0

69.2

70.6

NA

NA

 Precision, CV%

3.64

4.79

10.93

55.14

5.32

17.13

NA

NA

Inter-day

 Accuracy, %

91.75

105.08

90.09

70.8

82.6

84.14

NA

NA

 Precision, CV%

9.76

4.56

0.77

42.54

12.62

20.13

NA

NA

  1. The optimized analytical method for CYP2E1 quantification was validated by assessing the linear range, linearity, LLOQ, specificity, intra and inter-group accuracy and precision. IS-P1 internal standard for P1; IS-P2 internal standard for P2; NA not applicable. Coefficient of variation (CV, %) is presented as mean ± standard deviation. Coefficient of variation, means and standard deviations were calculated using the Sigma plot 11.2 software. Overall, the analytical method showed higher sensitivity and specificity for P1 (LLOQ = 5 fg µL−1; CV% = 4.0 ± 0.004) in comparison to P2 (LLOQ = 100 fg µL−1; CV% = 15.9 ± 0.42). Higher intra-day accuracy (L = 99.2 %; M = 99.8 %; H = 98.2 %) and precision (L: CV% = 3.64; M: CV% = 4.79; H: CV% = 10.93) were observed for quantification of P1 in comparison to P2 [(Accuracy) L = 41.0 %; M = 69.2 %; H = 70.6 % / (precision) L: CV% = 55.14; M: CV% = 5.32; H: CV% = 17.13]. Similarly, Inter-day accuracy for P1 (L = 91.75 %; M = 105.08%; H = 90.09 %) showed higher than 90 % accuracy for all levels of QC quantitated while P2 quantification showed slightly lower accuracy (L = 70.8 %; M = 82.6 %; H = 84.14 %) for all levels of QC in comparison to P1. Inter-day precision for quantification of P1 at all 3 QC levels showed CV% < 10 showing that the quantification method was highly precise for P1. P2 showed poor precision (L: CV% = 42.54 %; M: CV% = 12.62 and H: CV% = 20.13 %) for L and H QC levels. Overall, P1 showed higher reproducibility and reliability as representative peptide for CYP2E1 in the optimized targeted proteomic approach